Search articles in News

Filter Articles

Open filters

Sections

Found 2,566 articles

Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines
- 6 Mar 2024
- Editor
The rapid growth of Lantern Pharma’s AI platform could lead to accelerated development of better treatments, greater precision in clinical development, and improved combination regimens with the potential for longer and more durable patient responses.
Transgene, NEC and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
- 6 Mar 2024
- Editor
Transgene, NEC Corporation, and BostonGene Corporation (BostonGene), a leading company in AI-based molecular and immune profiling, today announced the expansion of their collaboration for the randomized Phase I/II trial of TG4050, an individualized therapeutic vaccine for patients with head and neck cancers.
Ariceum Therapeutics announces opening of new state-of-the-art laboratory in Berlin providing infrastructure for radiopharmaceutical development activities
- 6 Mar 2024
- Editor
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is pleased to announce the opening of its new laboratory facilities on 7 March at its Berlin headquarters to house the research and development of its next generation radiopharmaceutical pipeline candidates and support the transfer of advancing products into the clinic.
Top 9 Clinical Research Organisations in 2024
- 6 Mar 2024
- Lucy Walters
In terms of revenue, the global clinical trials market was estimated to be worth $48.2 billion in 2023 and is expected to reach $73.2 billion by 2028, growing at a CAGR of 8.7%. In this article, we’ve rounded up 9 of the top Clinical Research Organisations (CROs) in the world, highlighting the key drivers of this growth.
Novo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial
- 6 Mar 2024
- Editor
Novo Nordisk today announced the headline results from the kidney outcomes trial FLOW. The announcement today follows the decision to stop the trial early due to efficacy, which was announced on 10 October 2023, based on a recommendation from an Independent Data Monitoring Committee.
Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care
- 6 Mar 2024
- Editor
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam announced today that the Phase II KARDIA-2 study [NCT05103332] of zilebesiran, an investigational RNAi therapeutic in development for the treatment of hypertension (high blood pressure) - the leading cause of cardiovascular disease worldwide1 - met its primary endpoint.
Immutep Announces First Clinical Data from 90mg Dosing of Efti
- 6 Mar 2024
- Editor
Immutep (Formerly known as Prima Biomed) Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces safety and initial efficacy data from the first ever 90mg dosing of eftilagimod alpha (efti) in combination with weekly paclitaxel in patients from the safety lead-in (N=6) of the AIPAC-003 Phase II/III trial.
5 Clinical Research Recruitment Trends for 2024
- 5 Mar 2024
- Lucy Walters
The global clinical trials market size was valued at USD 80.7 billion in 2023 and is projected to grow at a CAGR of 6.49% from 2024 to 2030. Despite this anticipated growth, the clinical research industry has faced huge challenges over the past year, largely driven by political and economic turbulence.
CurifyLabs announces Jamie Campbell as New Board Chair to Further Boost Growth and Expansion
- 29 Feb 2024
- Editor
CurifyLabs, a leading health technology company providing automated solutions for producing personalized medicine, announces today the appointment of Jamie Campbell as the new Chair of the Board. This strategic appointment further strengthens CurifyLabs' position as the company continues growth in Europe and expansion to the North American market.
Bionical Solutions Appoints Chief Technology Officer to Create Innovative Data Products and Software for the Digital Business
- 29 Feb 2024
- Editor
Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announced the appointment of Andrew Seward as Chief Technology Officer for the Digital business.
BC Platforms Announces Executive Leadership Changes
- 29 Feb 2024
- Editor
BC Platforms AG (hereafter "BC Platforms") today announces that Tero Silvola, current CEO, is leaving the company, effective today. A new Executive office has been formed with current COO, Mikaela Bruhammar, appointed as interim CEO, together with CFO Kaj Työppönen.
Greenphire Adds Industry Veteran Dan Shannon as New Chief Experience Officer
- 29 Feb 2024
- Editor
Greenphire, a leading innovator in software solutions for improving clinical research site performance and participant satisfaction, today announced the addition of healthcare technology executive Dan Shannon as its new Chief Experience Officer (CXO). As CXO, he will oversee service delivery and steward the journey of continuous evolution toward an optimal client experience from beginning to end.
Aston Pharmacy School students benefit from generative AI simulation to prepare them for the real world
- 29 Feb 2024
- Editor
Aston Pharmacy School has introduced new generative artificial intelligence (AI) simulation software to train students in common situations they will encounter in practice and ensure they are properly prepared for their pharmacy placements.
Over a Third of Job Applicants Use ChatGPT When Applying for a Job
- 29 Feb 2024
- Editor
Hays, the world’s specialist leader in workforce solutions and recruitment, asked over 15,000 respondents whether they had used ChatGPT when applying for a job, 39% said they had used the generative AI tool to help with their CV/resume, which is a 13% increase from 2023.
Novavax’s Protein-based Non-mRNA COVID-19 Vaccine Available Now as Additional Dose for Individuals Aged 65 and Older Following U.S. CDC Advisory Committee Recommendation
- 29 Feb 2024
- Editor
Today, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted in favor (11 to 1; 1 abstain) to recommend that individuals aged 65 and older should receive an additional dose of 2023-2024 Formula COVID-19 vaccine (four months since receipt of the last dose).
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS
- 29 Feb 2024
- Editor
PharmAust Limited (ASX: PAA & PAAOA) ("PharmAust" or "the Company"), a clinical-stage biotechnology company, is pleased to announce that it has met its primary safety and tolerability endpoints with monepantel (MPL) and, importantly, demonstrated a positive signal of potential efficacy.
Curia Appoints Steve Lavezoli as Vice President, Biologics
- 28 Feb 2024
- Editor
Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.
A Recruiter’s Guide to Hiring a Pharmaceutical Product Manager
- 28 Feb 2024
- Lucy Walters
In this guide, we explore the essential steps and considerations for you to keep in mind when searching for a pharmaceutical product manager. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will provide you with valuable tips to help you focus your candidate search and engage top talent.
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
- 27 Feb 2024
- Editor
Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the addition of two experienced and highly respected industry veterans to its board of directors.
U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance
- 27 Feb 2024
- Editor
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved a new, expanded indication for Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat people with HIV (PWH) who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. HIV treatment resistance is permanent and irreversible, which can jeopardize future treatment options for PWH.